Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118561) titled 'Vonoprazan-Amoxicillin Dual Sequential Therapy For Helicobacter pylori-infected treatment-naive patients:A Randomized, Open-label, Parallel-controlled , Multicenter clinical trial' on Feb. 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Helicobacter pylori infection

Intervention: VAST-10:VA dual sequential therapy for 10 days VAST-14:VA dual sequential therapy for 14 days

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-04-26

Target Sample Size: VAS...